Design
Guideline
Loading...
Encourages mechanism-based antiarrhythmic selection in practice; extends traditional classifications for precision therapy.
Introduces the 'Sicilian Gambit', a novel, multifaceted framework for classifying antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms and molecular targets.
A 1991 study conducted a review in Arrhythmias. Antiarrhythmic drugs classification was evaluated. The 'Sicilian Gambit' proposes a new operational framework for classifying antiarrhythmic drugs based on molecular targets, arrhythmogenic mechanisms, and clinical considerations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: